Fred Biehl
Directeur/Membre du Conseil chez Aspargo Laboratories, Inc.
Profil
Fred Biehl currently works at Aspargo Laboratories, Inc., as Director.
Postes actifs de Fred Biehl
| Sociétés | Poste | Début |
|---|---|---|
Aspargo Laboratories, Inc.
 Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aspargo Laboratories, Inc.
Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ. | Health Technology |